ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

IKA Ilika Plc

30.50
0.50 (1.67%)
Last Updated: 08:31:15
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Ilika Plc LSE:IKA London Ordinary Share GB00B608Z994 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.50 1.67% 30.50 29.00 32.00 31.25 29.50 30.00 914,154 08:31:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 702k -7.3M -0.0459 -6.64 48.49M

Ilika plc Half-year Report (2817B)

09/01/2018 7:00am

UK Regulatory


Ilika (LSE:IKA)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Ilika Charts.

TIDMIKA

RNS Number : 2817B

Ilika plc

09 January 2018

Ilika plc

('Ilika,' the 'Company,' or the 'Group')

Half-year Report

Ilika (AIM: IKA), a pioneer in solid-state battery technology and materials innovation, announces its unaudited half yearly report for the six months ended 31 October 2017.

Operational Highlights

   --     Exchanged detailed Stereax(R) performance data with over 60 potential OEM partners 
   --     Shipped sample batteries to 10 potential OEM partners for detailed technical evaluation 
   --     Three of these have progressed to development and deployment partnerships: 

o Advanced a development programme to integrate a Stereax(R) battery in a miniature medical implant product (value to Ilika of GBP700,000 over 18 months from March 2017)

o Commenced a development programme to integrate a Stereax(R) battery with a photovoltaic energy harvesting solution from Lightricity (ex-Sharp) (value to Ilika of GBP320,000 over two years from July 2017)

o Secured a deployment programme with Titan Wind Energy, China's largest wind turbine manufacturer, to use Stereax(R) M250 batteries to power strain sensors for turbine blade condition monitoring (value to Ilika of GBP400,000 over two years from March 2018)

-- Continued to implement the Stereax(R) roadmap to achieve increased capacity per footprint and miniaturisation requirements

   --     Executed the following materials development programmes: 

o plasmonic lenses and Heat Assisted Magnetic Recording (HAMR) materials with Seagate

o battery materials with Johnson Matthey

o game changing energy materials with Toyota and

o aerospace alloys in collaboration with partners including Rolls Royce, GKN and BAE Systems.

   --     Expanded proprietary IP with patents granted in USA for core-shell catalysts for fuel cells 
   --     ISO 9001Certification achieved in December 2017 

Financial Summary

   --     Total revenue for the period GBP1.0m (H1 2016: GBP0.3m) 
   --     Loss per share 2p (H1 2016: 3p per share) 
   --     Cash balance at period end GBP3.9m (H1 2016: GBP7.1m) 

Commenting on the results Graeme Purdy, CEO of Ilika, said: "In the first half of the year Ilika has delivered a series of Stereax(R) development and deployment partnerships which are driving revenue growth and enhancing insight into the addressable sectors for its technology. The progress being made towards the commercialisation of Stereax technology is illustrated by the increased number of Stereax(R) samples sent to a diverse range of potential OEM partners for evaluation. Ilika is well-positioned to generate value from its globally-recognised reputation for expertise in solid-state materials and battery technology and is seeing increased corporate interest consistent with greater activity in the global battery sector."

 
 Ilika plc 
  Graeme Purdy, Chief Executive 
  Steve Boydell, Finance Director                              +44 (0)23 8011 1400 
 
 NUMIS Securities Limited 
  Paul Gillam/Oliver Cardigan/James 
  Black                                                       +44 (0) 20 7260 1000 
 
 Walbrook PR Ltd                       +44 (0)20 7933 8780 or ilika@walbrookpr.com 
 Paul McManus                                             Mob: +44 (0)7980 541 893 
 Paul Cornelius                                           Mob: +44 (0)7827 879 460 
 Lianne Cawthorne                                         Mob: +44 (0)7584 391 303 
 

Joint Chairman's and CEO's Statement

Review of Period

Ilika has continued to pursue its strategy of developing and commercialising its proprietary solid-state batteries, underpinned by its technology platform for the high throughput development of materials for the energy, electronics and aerospace sectors.

Stereax(R) solid-state battery technology

Ilika has been active in the development of solid-state battery technology since 2008, when it commenced a collaboration with Toyota, principally to develop materials suitable for use in batteries for hybrid vehicles. During that collaboration, Ilika and Toyota filed joint patent applications protecting relevant materials and processes for the development and manufacture of solid-state batteries. The key advantages of solid-state batteries relative to standard lithium-ion batteries are:

   --     Non-flammable 
   --     6 x faster charging 
   --     4x longer charge retention 
   --     2x increased energy density, making them half the volume for a given electrical charge 
   --     1/10(th) the leakage current. 

Ilika identified that these benefits make solid-state batteries particularly suitable for powering wireless sensors, which are the end-nodes for the "Internet of Things" (IoT). While analysts' estimates vary, we believe there are about 15 billion sensors already deployed, with the majority of these sensors hard-wired either to the grid, or to larger batteries, for example those used to power consumer electronics devices. Sensors can also be powered by primary (disposable) batteries. The number of sensors being deployed is growing rapidly and many of the important use-cases involve sensors in environments where it is expensive or inconvenient to connect them with cables. Also, in the trillion-sensor scenario, where sensors become ubiquitous, we understand the use of disposable coin cells becomes unsustainable. Ilika's solution is to combine its rechargeable Stereax(R) technology with miniature energy harvesters such as small photovoltaic panels (that convert light to electricity), thermoelectric devices (that convert heat to electricity) and piezoelectric devices (that convert movement to electricity).

Ilika's Stereax(R) battery technology is differentiated from other solid-state batteries through its choice of materials and its use of an efficient evaporation process that is capable of higher deposition rates than other solid-state routes. This results in the following benefits relative to previous solid-state battery designs:

-- Ability to stack cells in a continuous process prior to encapsulation, increasing the energy capacity per footprint of battery

   --     Less encapsulation required 
   --     High temperature resilience 

Within the IoT market, there are many segments which are addressable with Ilika's technology. The unique benefits of Stereax(R) batteries make them particularly useful for medical implants and industrial IoT applications. Miniature Stereax(R) batteries can enable medical devices in a way that is currently not possible with conventional lithium-ion batteries. Their compact, high energy density, high power characteristics make them useful for a range of medical implant applications covering blood pressure monitoring to neuro-stimulation. Industrial IoT, or Industry 4.0 as it is sometimes referred to, requires batteries that can reliably operate at elevated temperatures above those for which standard lithium-ion batteries are rated.

In discussion with its potential partners, Ilika has defined a development roadmap for its Stereax(R) batteries. The Stereax(R) M250 product was launched in 2016 and in 2017 this was followed up with the launch of the P180, designed for use in hostile environments. Further Stereax(R) product launches are expected in 2018. Ilika has entered into in excess of 60 application discussions with potential OEM partners around the world. In addition, Ilika has sent samples of batteries to 10 potential partners for their detailed evaluation and validation. Three of these discussions have now progressed to development and deployment partnerships, which are discussed in the commercial section below.

The Stereax products that Ilika is marketing to its partners are defined by a licensing package including the following:

   --     Battery architecture design 
   --     Detailed definition of the materials composition and properties 
   --     Manufacturing process description 
   --     Sample battery devices 
   --     IP portfolio 

Over the past few months Ilika has been approached by a number of significant commercial partners interested in collaborating with Ilika to expand its product development roadmap to include larger capacity batteries suitable for use in consumer electronics, domestic storage of energy and electric powered vehicles. In order to address these applications, Ilika is developing manufacturing processes suitable for forming battery materials in quantities which facilitate energy storage on a scale several orders of magnitude larger than that achievable using current vacuum deposition methods. The Stereax roadmap is now showing this technical innovation, which has the code-name "Goliath". Further information will be forthcoming on this development path in future updates.

Commercial Progress

Ilika's intention is to license its technology to OEM partners using the model that has become standard in the semiconductor industry, based on license fees and royalties. Using its pilot line, Ilika has produced samples of its M250 and P180 batteries, which it has used to provide initial quantities of product to seed the market for OEM's. Licensing may also involve the use of 3(rd) party foundries working under contract to OEM's.

Ilika has continued to pursue a three-phase strategy for the commercialisation of its battery technology:

   --     Optimisation of the battery architecture for specific applications 
   --     Validation and integration of the batteries into application systems 
   --     Technology transfer and licensing for manufacture 

The development of the published Stereax roadmap is demonstration of the implementation of the first phase of this strategy. The second phase commenced in 2017, as demonstrated by the three development and deployment programmes announced in the course of the year:

1. The optimisation of Stereax technology for miniature medical implants announced in March 2017 which is a GBP700k development programme.

2. Integration of Stereax with photovoltaic harvesters for transport applications in a two-year programme with Lightricity (ex-Sharp), which started in July 2017.

3. Deployment of Stereax in sensors to measure strain for condition monitoring in wind turbine blades. This programme will start in March 2018 and is a collaboration with Titan Wind Energy, China's largest wind turbine manufacturer.

These three programmes can be seen as lead indicators of the areas into which Stereax technology will be licensed as part of the third phase of commercialisation.

Materials Development Portfolio

Ilika continues to support an active portfolio of materials development projects, which are carried out in collaboration with OEM partners. These programmes are a usually done on a shared-IP basis. The project fees make a significant contribution towards covering Ilika's overheads.

Energy materials

In February 2017 Ilika commenced the latest in a series of projects with the Toyota Group. This latest project is being carried out with the Toyota Research Institute and its partners in the USA. The project involves the use of materials modelling, machine learning and Ilika's automated materials synthesis and testing techniques.

In August 2016, Ilika announced that it is taking part in a three-year project to develop protected anodes for lithium sulphur batteries. Led by Johnson Matthey and including Williams Grand Prix Engineering Ltd, the University of Oxford and the University of Warwick. The aim of the project is to discover new electrolyte composition options which will provide enhanced performance 'pouch cells' that can be made with existing cell fabrication methods. The pouch cells being developed in this project are for large scale renewable energy storage applications that require high capacity and low-cost batteries.

Electronic materials

In February 2017 Ilika announced a second project with Seagate to develop photonic materials and processes for hard drives. This follows on from the two-year project with Seagate and the University of Southampton, which commenced in February 2016, with the aim of providing a demonstration of 2D materials for Hard Disk Drive applications. Materials with superior nanophotonic properties are being developed to achieve improved hard drive performance and reliability.

Aerospace Alloys

Ilika has continued in its role of leading two aerospace alloy programmes. The first is focussing on superalloy compositions for gas turbine engines with better thermal efficiency than current alloys. The alloys are designed to increase gas turbine performance, reducing CO(2) emissions and noise levels at take-off. This is a collaboration with the University of Cambridge, Diamond Light Source and Rolls Royce.

The second project is the development of self-healing alloys in collaboration with Reliance Precision Engineering, University of Sheffield, GKN and BAE Systems. This project aims to develop alloys suitable for additive manufacturing processes and to develop a metallic manufacturing process that takes advantage of the flexibility of additive manufacturing and the precision of subtractive manufacturing.

Outlook

In the second half of the current financial year Ilika expects to continue to deliver strong revenue growth relative to the previous year. Ilika is focussed on the scale up of its Stereax technology. An important milestone in this process has been the award of ISO 9001 certification to the Company.

In addition, Ilika's pipeline of potential OEM partners, who are actively evaluating Stereax batteries, demonstrates that the Company is drawing ever closer to licensing this technology. Ilika is well-positioned to exploit the global trend towards solid-state battery technology and is one of the few global players with an established technology position in this field. Underpinning this is Ilika's foundation of high throughput materials innovation, which continues to attract OEM collaboration partners and support revenue growth.

Graeme Purdy, CEO

Mike Inglis, Chairman

Ilika plc

Consolidated statement of comprehensive income for the six months ended 31 October 2017

 
                                                  Unaudited       Unaudited        Audited 
                                                  Six months      Six months         Year 
                                                    ended           ended           ended 
                                                 31 Oct 2017     31 Oct 2016     30 Apr 2017 
                                        Notes        GBP             GBP             GBP 
-------------------------------------  ------  --------------  --------------  -------------- 
 
 Turnover                                           1,004,112         328,639       1,050,667 
-------------------------------------  ------  --------------  --------------  -------------- 
 Revenue                                              413,572          54,807         311,946 
 UK grants                                            590,540         273,832         738,721 
-------------------------------------  ------  --------------  --------------  -------------- 
 
 Cost of sales                                      (531,024)       (220,101)       (574,272) 
 
 Gross profit                                         473,088         108,538         476,395 
 Administrative expenses 
-------------------------------------  ------  --------------  --------------  -------------- 
 Administrative expenses                          (1,897,903)     (2,030,138)     (3,863,411) 
 Share-based payment charge                         (269,627)       (278,326)       (547,347) 
-------------------------------------  ------  --------------  --------------  -------------- 
                                                    2,167,530       2,308,464       4,410,758 
 
 Operating loss                                   (1,694,442)     (2,199,926)     (3,934,363) 
 
 Financial income                                       8,654           5,822          23,844 
 
 
 Loss before tax                                  (1,685,788)     (2,194,104)     (3,910,519) 
 Taxation                                             198,308         217,268         370,274 
 
 Loss for period/total comprehensive 
  income attributable to owners 
  of parent                                       (1,487,480)     (1,976,836)     (3,540,245) 
 
 Loss per share 
 Basic and diluted                        2            (0.02)          (0.03)          (0.05) 
                                               --------------  --------------  -------------- 
 

The results from the periods shown above are derived entirely from continuing operations.

Consolidated balance sheet as at 31 October 2017

 
                                                 Unaudited      Unaudited       Audited 
                                                 Six months     Six months        Year 
                                                    ended          ended          ended 
                                                 31 Oct 2017    31 Oct 2016      30 Apr 
                                                                                  2017 
                                       Notes        GBP            GBP            GBP 
------------------------------------  -------  -------------  -------------  ------------- 
 ASSETS 
 Non-current assets 
 Intangible assets                                     2,980          9,088          2,581 
 Property, plant and equipment                       543,653        405,573        451,560 
                                               -------------  -------------  ------------- 
 
 Total non-current assets                            546,633        414,661        454,141 
                                               -------------  -------------  ------------- 
 
 Current assets 
 Trade and other receivables                       1,015,866        674,539      1,116,367 
 Current tax receivable                              528,309        240,274        330,000 
 Other financial assets - bank 
  deposits                                         3,268,648      1,406,305      2,900,000 
 Cash and cash equivalents                           601,499      5,665,033      2,510,884 
                                               -------------  -------------  ------------- 
 
 Total current assets                              5,414,322      7,986,151      6,857,251 
                                               -------------  -------------  ------------- 
 
 Total assets                                      5,960,955      8,400,812      7,311,392 
                                               -------------  -------------  ------------- 
 
 
 Issued capital and reserves attributable 
  to owners of parent 
 Issued share capital                                789,911        789,911        789,911 
 Share premium                                    23,179,756     23,179,756     23,179,756 
 Capital restructuring reserve                     6,486,077      6,486,077      6,486,077 
 Retained earnings                              (25,424,258)   (22,912,018)   (24,206,405) 
                                               -------------  -------------  ------------- 
 
 Total equity                                      5,031,486      7,543,726      6,249,339 
                                               -------------  -------------  ------------- 
 
 
 LIABILITIES 
 Current liabilities 
 Trade and other payables                            779,469        707,086        912,053 
 Provisions                                          150,000        150,000        150,000 
                                               -------------  -------------  ------------- 
 
 Total liabilities                                   929,469        857,086      1,062,053 
                                               -------------  -------------  ------------- 
 
 Total equity and liabilities                      5,960,955      8,400,812      7,311,392 
                                               -------------  -------------  ------------- 
 

Consolidated cash flow statement for the six months ended 31 October 2017

 
                                               Unaudited      Unaudited       Audited 
                                               Six months     Six months        Year 
                                                  ended          ended          ended 
                                               31 Oct 2017    31 Oct 2016    30 Apr 2017 
                                                  GBP            GBP            GBP 
-------------------------------------------  -------------  -------------  ------------- 
 Cash flows from operating activities 
 Loss before taxation                          (1,685,788)    (2,194,104)    (3,910,519) 
 Adjustments for: 
 Amortisation                                        2,755          6,507         13,014 
 Depreciation                                       99,798         99,926        192,331 
 Equity settled share based payments               269,627        278,326        547,347 
 Profit on disposal of plant, property 
  and equipment                                          -       (30,129)       (30,783) 
 Net financial income                              (8,654)        (5,822)       (23,844) 
                                             -------------  -------------  ------------- 
 Operating cash flow before changes 
  in working capital, interest and 
  taxes                                        (1,322,262)    (1,845,296)    (3,212,454) 
 Decrease/(increase) in trade and 
  other 
  receivables                                      100,501      (119,850)      (598,672) 
 Increase /(decrease) in trade and 
  other payables                                 (132,584)       (41,043)        163,925 
                                             -------------  -------------  ------------- 
 Cash utilised by operations                   (1,354,345)    (2,006,189)    (3,647,201) 
 Tax received                                            -        315,000        415,274 
                                             -------------  -------------  ------------- 
 Net cash flow from operating activities       (1,354,345)    (1,691,189)    (3,231,927) 
 
 Cash flows from investing activities 
 Interest received                                   8,653          5,822         23,844 
 Sale of property plant and equipment                    -         30,129         40,129 
 Purchase of intangible assets                     (3,154)              -              - 
 Purchase of property, plant and equipment       (191,891)      (106,175)      (253,913) 
 Increase in other financial assets              (368,648)    (1,406,305)    (2,900,000) 
                                             -------------  -------------  ------------- 
 Net cash used in investing activities           (555,040)    (1,476,529)    (3,089,940) 
 
 Cash flows from financing activities 
 Proceeds from issuance of ordinary 
  share capital                                          -      6,300,000      6,300,000 
 Cost of share issue                                     -      (464,661)      (464,661) 
                                             -------------  -------------  ------------- 
 Net cash from financing activities                      -      5,835,339      5,835,339 
                                             -------------  -------------  ------------- 
 
 Net (decrease)/ increase in cash 
  and cash equivalents                         (1,909,385)      2,667,621      (486,528) 
 
 Cash and cash equivalents at the 
  start of the period                            2,510,884      2,997,412      2,997,412 
 
 Cash and cash equivalents at the 
  end of the period                                601,499      5,665,033      2,510,884 
                                             =============  =============  ============= 
 

Consolidated statement of changes in equity (unaudited)

 
                                          Share premium      Capital 
                                             account       restructuring      Retained 
                          Share capital                       reserve         earnings          Total 
                              GBP              GBP             GBP              GBP             GBP 
---------------------  ----------------  --------------  ---------------  --------------  -------------- 
 As at 30 April 
  2016                          663,911      17,470,417        6,486,077    (21,213,507)       3,406,898 
 Issue of shares                126,000       6,174,000                -               -       6,300,000 
 Expenses of share 
  issue                               -       (464,661)                -               -       (464,661) 
 Share-based payment                  -               -                -         278,326         278,326 
 Loss and total 
  comprehensive 
  income                              -               -                -     (1,976,836)     (1,976,836) 
                                                                          --------------  -------------- 
 As at 31 October 
  2016                          789,911      23,179,756        6,486,077    (22,912,017)       7,543,727 
 Share-based payment                  -               -                -         269,021         269,021 
 Loss and total 
  comprehensive 
  income                              -               -                -     (1,563,409)     (1,563,409) 
                                                                          --------------  -------------- 
 As at 30 April 
  2017                          789,911      23,179,756        6,486,077    (24,206,405)       6,249,339 
 Share-based payment                  -               -                -         269,627         269,627 
 Loss and total 
  comprehensive 
  income                              -               -                -     (1,487,480)     (1,487,480) 
 As at 31 October 
  2017                          789,911      23,179,756        6,486,077    (25,424,258)       5,031,486 
 

Share capital

The share capital represents the nominal value of the equity shares in issue.

Share premium account

When shares are issued, any premium paid above the nominal value is credited to the share premium reserve.

Retained earnings

The retained earnings reserve records the accumulated profits and losses of the Group since inception of the business.

Capital restructuring reserve

The capital restructuring reserve arises on the accounting for the share for share exchange. It represents the difference between the value of the issued equity instruments of Ilika Technologies Limited immediately before the share for share exchange and the equity instruments of Ilika plc along with the shares issued to effect the share for share exchange.

Notes to the consolidated financial statements

   1.      Accounting policies 

Basis of preparation

The interim financial statements, which are unaudited, have been prepared on the basis of accounting policies consistent with International Financial Reporting Standards ("IFRSs") adopted by the European Union. The accounting policies are the same as applied in the Group's latest financial statements.

The interim financial statements do not include all of the information required for full annual financial statements and do not comply with all the disclosures in IAS 34 'Interim Financial Reporting'. Accordingly, whilst the interim financial statements have been prepared in accordance with IFRS they cannot be construed as being in full compliance with IFRS.

The financial information for the year ended 30 April 2017 does not constitute the full statutory accounts for that period. The Annual Report and Accounts for 30 April 2017 have been filed with the Registrar of Companies. The Independent Auditors' Report on the Annual Report and Accounts for 2017 was unqualified and did not include references to any matters which the auditors drew attention by way of emphasis without qualifying their report and did not contain statements under Section 498(2) or 498(3) of the Companies Act 2006.

Going concern

The financial statements are prepared on a going concern basis which the directors believe continues to be appropriate. The Group meets its day to day working capital requirements through existing cash resources which, at 31 October 2017, amounted to GBP3.9m. The directors have prepared projected cash flow information for the period ending twelve months from the date of their approval of these financial statements. On the basis of this cash flow information the directors believe that the Group will be able to continue to trade for the foreseeable future.

   2.      Loss per share 

Loss per ordinary share have been calculated using the weighted average number of shares in issue during the relevant financial periods. The weighted average number of equity shares in issue and the earnings, being loss after tax, are as follows:

 
                                       Unaudited      Unaudited       Audited 
                                       Six months     Six months        Year 
                                          ended          ended          ended 
                                       31 Oct 2017    31 Oct 2016    30 Apr 2016 
                                         Number         Number         Number 
-----------------------------------  -------------  -------------  ------------- 
 
 Weighted average number of equity 
  shares                                78,991,110     67,144,371     73,122,617 
 
                                          GBP            GBP            GBP 
-----------------------------------  -------------  -------------  ------------- 
 
 Loss, being loss after tax            (1,487,480)    (1,976,836)    (3,540,245) 
 
 

The loss attributable to ordinary shareholders and weighted average number of ordinary shares for the purpose of calculating the diluted earnings per ordinary share are identical to those used for basic earnings per share. This is because the exercise of share options and warrants would have the effect of reducing the loss per ordinary share and is therefore not dilutive under the terms of IAS 33.

- Ends -

This information is provided by RNS

The company news service from the London Stock Exchange

END

IR DVLFBVFFXBBE

(END) Dow Jones Newswires

January 09, 2018 02:00 ET (07:00 GMT)

1 Year Ilika Chart

1 Year Ilika Chart

1 Month Ilika Chart

1 Month Ilika Chart

Your Recent History

Delayed Upgrade Clock